Is the A5374 trial therapy safe?

The trial is designed to evaluate not just how well the therapy works, but also its safety and tolerability. Participants are closely monitored for any side effects or health concerns throughout the study.

Can this therapy cure HIV?

The A5374 trial is testing a step toward what’s called a 'functional cure.' While it may not eliminate the virus completely, the goal is to suppress HIV to the point where daily ART isn’t needed.

How could this trial change HIV treatment?

If successful, this trial could pave the way for treatments that allow people with HIV to live without daily ART. It represents a significant step toward simplifying HIV care and improving quality of life.

What makes this trial different from previous HIV studies?

The A5374 trial combines three cutting-edge therapies designed to boost the immune system and reduce HIV reservoirs. It also involves a monitored pause in ART to assess whether the virus can be controlled without daily medication.

When will the results of the A5374 trial be available?

Results will be analyzed and shared after the trial is completed, which could take several years. The findings will inform the next steps in HIV research.